EP Patent

EP0724581B1 — Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof

Assigned to Syntex USA LLC · Expires 1998-11-18 · 27y expired

What this patent protects

The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associ…

USPTO Abstract

The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment.

Drugs covered by this patent

Patent Metadata

Patent number
EP0724581B1
Jurisdiction
EP
Classification
—
Expires
1998-11-18
Drug substance claim
No
Drug product claim
No
Assignee
Syntex USA LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.